User:Mr. Ibrahem/Icatibant

Icatibant, sold under the brand name Firazyr, is a medication used to treat attacks of hereditary angioedema (HAE) in people with insufficient C1-esterase inhibitor. It does not appear effective for angioedema due to ACE inhibitors. It is given by injection under the skin.

Common side effects include redness, itching, and pain at the site of injection. Other side effects may include fever, headache, and nausea. Safety in pregnancy is unclear. It is a bradykinin B2 receptors inhibitor.

Icatibant was approved for medical use in Europe in 2008 and the United States in 2011. In the United Kingdom it costs the NHS about £1,400 per dose. In the United States this amount costs about 3,600 USD.